DocGo (NASDAQ:DCGO) Shares Up 1.2% – Still a Buy?

DocGo Inc. (NASDAQ:DCGO) rose 1.2% during trading on Thursday . The company traded as high as $0.9191 and last traded at $0.8972. Approximately 547,351 shares were traded during mid-day trading, a decline of 7% from the average daily volume of 590,594 shares. The stock had previously closed at $0.8864.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on DCGO shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DocGo in a research note on Monday, December 29th. Canaccord Genuity Group dropped their price objective on DocGo from $1.60 to $1.50 and set a “buy” rating on the stock in a report on Wednesday, November 12th. Finally, Zacks Research upgraded shares of DocGo from a “strong sell” rating to a “hold” rating in a research note on Thursday, November 6th. Two investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $3.21.

DocGo Stock Performance

The stock has a 50 day moving average of $0.96 and a two-hundred day moving average of $1.26. The firm has a market capitalization of $87.76 million, a P/E ratio of -1.73 and a beta of 0.94.

DocGo (NASDAQ:DCGO) last announced its earnings results on Monday, November 10th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.02). DocGo had a negative return on equity of 9.11% and a negative net margin of 14.02%.The company had revenue of $70.81 million for the quarter, compared to the consensus estimate of $69.96 million. Sell-side analysts predict that DocGo Inc. will post 0.25 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of DCGO. P.A.W. Capital Corp boosted its holdings in DocGo by 60.0% during the second quarter. P.A.W. Capital Corp now owns 3,200,000 shares of the company’s stock valued at $5,024,000 after acquiring an additional 1,200,000 shares during the period. S Squared Technology LLC lifted its position in shares of DocGo by 52.2% during the 2nd quarter. S Squared Technology LLC now owns 2,878,286 shares of the company’s stock worth $4,519,000 after purchasing an additional 987,310 shares during the last quarter. Millennium Management LLC boosted its stake in DocGo by 878.6% during the 3rd quarter. Millennium Management LLC now owns 766,210 shares of the company’s stock valued at $1,042,000 after purchasing an additional 687,911 shares during the period. AQR Capital Management LLC boosted its stake in DocGo by 219.1% during the 1st quarter. AQR Capital Management LLC now owns 476,645 shares of the company’s stock valued at $1,258,000 after purchasing an additional 327,269 shares during the period. Finally, JPMorgan Chase & Co. grew its holdings in DocGo by 92.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 557,613 shares of the company’s stock valued at $758,000 after buying an additional 267,259 shares during the last quarter. Institutional investors own 56.44% of the company’s stock.

About DocGo

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.